With the emergence and long-term Impact of COVID-19, Global Bloodstream Infection Testing Market to reach USD 980.01 Million by 2030
Bizwit Research & Consulting LLP’s recent analysis on the Global Bloodstream Infection Testing Market points towards a potential rise to USD 980.01 Million by 2030. Bloodstream infection testing, also known as blood culture testing, is a medical diagnostic procedure that is used to detect the presence of microorganisms, such as bacteria, fungi, and sometimes viruses, in a patient’s bloodstream. It is a critical diagnostic tool in clinical medicine for identifying and managing sepsis, a severe and potentially life-threatening condition that occurs when the body’s response to infection causes harm to its own tissues and organs.
This plays a vital role in investigating the bacteria and pathogens accountable for bloodstream infections. There is a heightened risk of infectious diseases spreading particularly in densely populated regions with limited hygiene practices, posing a significant threat to public health. This presents a challenge for public health management, necessitating efficient diagnostic approaches to identify and contain these infections. The global rise in infectious diseases and the growing awareness and focus on infection control stand out as key drivers propelling the market growth during the estimated period.
Geographically, the global Bloodstream Infection Testing market has been segmented into North America, Europe, Asia Pacific (APAC), Latin America, and Middle East and Africa (MEA). North America dominated the market in 2022 owing to the increased disposable income, the presence of well-established healthcare infrastructure, favorable reimbursement policies, and a growing number of strategic endeavors and product launches by major industry players. Additionally, the surge in demand for rapid diagnostic tests, as well as growing awareness of healthcare-associated infection is further propelling the market demand across the region.
Whereas, Asia Pacific is expected to grow at the highest CAGR over the forecast years. The growing investment in technological advancements and increasing number of government initiatives are significantly propelling the market demand across the region. Also, the increasing prevalence of chronic diseases, the rising aging population, along with shift towards patient-centered care and personalized medicine are further promoting the regional market expansion.
The global Bloodstream Infection Testing market is highly competitive owing to the presence of several key players such as BioMérieux SA Becton, Dickinson and Company Cepheid. Seegene Inc. T2 Biosystems, Inc. F. Hoffmann-La Roche Ltd Siemens Healthcare GmbH Luminex Corporation. Bruker Accelerate Diagnostics, Inc., and others.
For further analysis on this or to request a sample copy of this report, please click the link mentioned below:
Global Bloodstream Infection Testing Market Size Study & Forecast, by Product (Reagents & Consumables, Instruments), by Sample Type (Whole Blood, Blood Culture), by Technology (PCR, Mass Spectroscopy, In Situ Hybridization, Others), by End-use (Hospitals & Diagnostic Centers, Custom Laboratory Service Providers, Others), and Regional Analysis, 2023-2030
Key findings of the study suggest:
- Global Bloodstream Infection Testing Market is anticipated to grow with a healthy growth rate of more than 4.5% over the forecast period 2023-2030.
- In the Product segment, Reagents & Consumables emerged out as the leading market segment in 2022.
- North America is anticipated to drive regional growth owing to the increased disposable income, the presence of well-established healthcare infrastructure, favorable reimbursement policies, and a growing number of strategic endeavors and product launches by major industry players.
- Asia Pacific is expected to grow at higher rate followed by Europe during 2023-2030.
Bizwit Research & Consulting has considered following segments for the study:
- Reagents & Consumables
By Sample Type:
- Whole Blood
- Blood Culture
- Mass Spectroscopy
- In Situ Hybridization
- Hospitals & Diagnostic Centers
- Custom Laboratory Service Providers
- Academic & Research Institutes
- North America
- Asia Pacific
- Latin America
- Rest of Latin America
- Middle East & Africa
- Saudi Arabia
- South Africa
- Rest of Middle East & Africa
To get a sample of this report or to purchase a copy of the study, you can directly contact us at: email@example.com
Bizwit Research & Consulting LLP is a global provider of business intelligence & consulting services. The company has a strong primary base of key industry leaders along with the chain of industry analysts to analyze the market trends and its future impact in order to estimates and forecast different business segments and markets. Bizwit incorporate big data, expert analysis, and huge industry database to deliver client focused business consulting reports. Our analysts perform unbiased measurement and assessment of market opportunities to comprehend detailed market forecast. Our team of key opinion leaders evaluates the market size, growth prospects, end-use, applications, value & supply chain and top vendors in the industry to help the clients to take conversant business decisions without any vague assumptions.
Global Business Development
Phone: +1 209 498-3066